Market Place
Sourcing Support
VectivBio buys out small Massachusetts biotech, focus on metabolic disease
31 Aug 2021 //
ENDPTS
Gene therapy player InnoSkel debuts with €20M
15 Dec 2020 //
FIERCE BIOTECH
Pfizer Completes Acquisition of Therachon
01 Jul 2019 //
BIOSPACE
Therachon to Present Data from Ongoing PhII Study of Apraglutide for (SBS)
17 May 2019 //
PR NEWSWIRE
Pfizer expands rare disease pipeline with $820m buyout
10 May 2019 //
BIOPHARMA-REPORTER
Pfizer offers $340M upfront to buy Therachon for dwarfism drug
09 May 2019 //
FIERCE BIOTECH
Therachon announces Apraglutida has received orphan drug designation in EU
22 Mar 2019 //
PRNEWSWIRE
Therachon is Granted Orphan Drug Designation by US FDA for Apraglutide
18 Jan 2019 //
PR NEWSWIRE
Rare disease startup Therachon to absorb GLyPharma and its SBS candidate
10 Oct 2018 //
FIERCE BIOTECH
Therachon Raises $60 Million Mezzanine Financing to Advance Lead Program
14 Aug 2018 //
BUSINESSWIRE
Therachon appoints Christian Meyer as chief medical officer
04 Sep 2017 //
PMLIVE
Meyer leaves troubled uniQure for R&D post at Therachon
30 Aug 2017 //
FIERCE BIOTECH
Therachon Bags $35 Million Financing
30 Sep 2015 //
BIOSPACE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.